MAGNESIUM SULFATE

MAGNESIUM SULFATE was reported 13182 times

MAGNESIUM SULFATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 NORMAL LABOUR 107 0.7643
1 VAGINAL FLATULENCE 154 0.5083
2 MITOCHONDRIAL DNA MUTATION 30 0.3488
3 NEONATAL INTESTINAL PERFORATION 12 0.3333
4 DELIVERY 108 0.1639
5 HYPERMAGNESAEMIA 104 0.1593
6 CSF OLIGOCLONAL BAND PRESENT 20 0.1538
7 BURKHOLDERIA TEST POSITIVE 16 0.1290
8 NEGATIVE PRESSURE PULMONARY OEDEMA 11 0.1122
9 FEMALE GENITAL TRACT FISTULA 163 0.0954
10 AIRWAY PEAK PRESSURE INCREASED 13 0.0855
11 PCO2 INCREASED 50 0.0702
12 NEUROMUSCULAR BLOCKADE 15 0.0670
13 RADICULOPATHY 165 0.0625
14 PO2 INCREASED 30 0.0592
15 RENAL ISCHAEMIA 32 0.0585
16 TACHYCARDIA FOETAL 28 0.0561
17 PROCTITIS 154 0.0549
18 CHRONIC SINUSITIS 206 0.0548
19 PROPOFOL INFUSION SYNDROME 38 0.0539
20 ADRENAL SUPPRESSION 45 0.0534
21 BLOOD MAGNESIUM INCREASED 48 0.0532
22 BLOOD GASES ABNORMAL 28 0.0519
23 APGAR SCORE LOW 56 0.0434
24 NEUROMUSCULAR BLOCK PROLONGED 16 0.0434
25 STATUS ASTHMATICUS 19 0.0403
26 MACULAR DEGENERATION 463 0.0387
27 RESPIRATORY TRACT INFECTION BACTERIAL 19 0.0382
28 ECLAMPSIA 14 0.0381
29 HELLP SYNDROME 23 0.0375
30 PLEOCYTOSIS 20 0.0344
31 BRADYCARDIA FOETAL 28 0.0337
32 BLOOD PH DECREASED 57 0.0333
33 INTRAVENTRICULAR HAEMORRHAGE NEONATAL 16 0.0329
34 DIABETES INSIPIDUS 79 0.0328
35 LOW BIRTH WEIGHT BABY 258 0.0324
36 NEONATAL INFECTION 11 0.0318
37 MATERNAL EXPOSURE DURING DELIVERY 31 0.0313
38 FOETAL HEART RATE DECELERATION ABNORMALITY 20 0.0283
39 POSTPARTUM HAEMORRHAGE 38 0.0282
40 PREMATURE DELIVERY 428 0.0269
41 BLOOD BICARBONATE DECREASED 50 0.0264
42 MACROGLOSSIA 14 0.0255
43 LUNG HYPERINFLATION 21 0.0244
44 METAL POISONING 14 0.0241
45 PREMATURE BABY 686 0.0228
46 PRE-ECLAMPSIA 101 0.0212
47 URETERIC STENOSIS 17 0.0212
48 C-REACTIVE PROTEIN DECREASED 13 0.0199
49 FOETAL DISTRESS SYNDROME 41 0.0193
50 NEONATAL RESPIRATORY DISTRESS 18 0.0191
51 KLEBSIELLA TEST POSITIVE 12 0.0184
52 NEONATAL RESPIRATORY DISTRESS SYNDROME 65 0.0184
53 SACRAL PAIN 11 0.0181
54 AMNIOTIC CAVITY INFECTION 13 0.0180
55 TERMINAL ILEITIS 11 0.0179
56 PO2 DECREASED 20 0.0174
57 NEONATAL DISORDER 27 0.0170
58 FOETAL DEATH 88 0.0170
59 HYPOMAGNESAEMIA 234 0.0168
60 ENDOMETRITIS 11 0.0165
61 BRONCHOPULMONARY DYSPLASIA 13 0.0161
62 SEPSIS NEONATAL 13 0.0160
63 PARAESTHESIA ORAL 230 0.0159
64 VAGINAL DISCHARGE 158 0.0156
65 NEONATAL ASPHYXIA 11 0.0155
66 GENE MUTATION 30 0.0151
67 LYMPHOCELE 10 0.0151
68 DRUG-DISEASE INTERACTION 11 0.0150
69 PERINEAL PAIN 10 0.0140
70 RESPIRATORY ACIDOSIS 55 0.0140
71 PLACENTAL DISORDER 13 0.0137
72 BLOOD MAGNESIUM DECREASED 115 0.0133
73 CEREBRAL VENTRICLE DILATATION 15 0.0130
74 ORAL CANDIDIASIS 168 0.0127
75 GINGIVAL DISORDER 49 0.0127
76 TETANY 23 0.0126
77 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 74 0.0125
78 OXYGEN SATURATION ABNORMAL 35 0.0123
79 FUNGAL SEPSIS 10 0.0120
80 DRUG EXPOSURE VIA BREAST MILK 13 0.0119
81 HYPERCAPNIA 35 0.0116
82 ABDOMINAL SEPSIS 10 0.0114
83 BLOOD UREA DECREASED 14 0.0113
84 TORSADE DE POINTES 88 0.0112
85 HYPOTONIA NEONATAL 17 0.0109
86 KLEBSIELLA SEPSIS 12 0.0106
87 BLOOD LACTIC ACID INCREASED 56 0.0106
88 CYTOKINE RELEASE SYNDROME 213 0.0106
89 ELECTROENCEPHALOGRAM ABNORMAL 33 0.0104
90 PREMATURE SEPARATION OF PLACENTA 16 0.0104
91 PNEUMONIA KLEBSIELLA 19 0.0103
92 BREECH PRESENTATION 13 0.0103
93 PREMATURE LABOUR 58 0.0102
94 PRODUCT CONTAMINATION MICROBIAL 12 0.0101
95 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 14 0.0099
96 VITH NERVE PARALYSIS 11 0.0096
97 PATENT DUCTUS ARTERIOSUS 38 0.0096
98 INCISION SITE PAIN 11 0.0094
99 PNEUMOPERITONEUM 17 0.0092
100 MULTI-ORGAN FAILURE 156 0.0090
101 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 34 0.0089
102 FUNGAEMIA 14 0.0089
103 HYPOCALCAEMIA 167 0.0088
104 ISCHAEMIC HEPATITIS 12 0.0088
105 MATERNAL EXPOSURE DURING PREGNANCY 770 0.0086
106 HYPERNATRAEMIA 43 0.0086
107 FOETAL EXPOSURE DURING PREGNANCY 701 0.0086
108 APLASTIC ANAEMIA 45 0.0086
109 RESPIRATORY TRACT INFECTION VIRAL 20 0.0086
110 LEFT VENTRICULAR DYSFUNCTION 57 0.0085
111 CAESAREAN SECTION 99 0.0085
112 PANCREATITIS CHRONIC 20 0.0084
113 MYASTHENIA GRAVIS CRISIS 12 0.0081
114 ACUTE PULMONARY OEDEMA 45 0.0080
115 NECROTISING COLITIS 10 0.0079
116 SMALL FOR DATES BABY 39 0.0078
117 HYPOREFLEXIA 15 0.0078
118 METHAEMOGLOBINAEMIA 18 0.0078
119 MULTIPLE-DRUG RESISTANCE 24 0.0077
120 ANTINUCLEAR ANTIBODY POSITIVE 25 0.0077
121 CLONUS 21 0.0077
122 BRONCHIECTASIS 51 0.0076
123 SYSTEMIC CANDIDA 19 0.0076
124 HAEMODYNAMIC INSTABILITY 57 0.0075
125 ORAL DISORDER 54 0.0074
126 METABOLIC ENCEPHALOPATHY 22 0.0073
127 HEPARIN-INDUCED THROMBOCYTOPENIA 36 0.0073
128 EXPOSURE DURING PREGNANCY 448 0.0072
129 TOXIC EPIDERMAL NECROLYSIS 108 0.0071
130 PROCEDURAL PAIN 197 0.0071
131 BACTERIAL SEPSIS 23 0.0071
132 PREMATURE RUPTURE OF MEMBRANES 17 0.0070
133 BLOOD CHLORIDE DECREASED 18 0.0070
134 ACUTE RESPIRATORY FAILURE 134 0.0070
135 BLOOD ALBUMIN DECREASED 55 0.0069
136 STILLBIRTH 33 0.0068
137 LUNG CONSOLIDATION 19 0.0068
138 HYPERLACTACIDAEMIA 18 0.0067
139 LARYNGOSPASM 18 0.0067
140 HYPOALBUMINAEMIA 52 0.0067
141 PRODUCT PACKAGING CONFUSION 16 0.0066
142 PNEUMONIA STAPHYLOCOCCAL 13 0.0066
143 ATELECTASIS 63 0.0065
144 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 18 0.0065
145 HYPOPHOSPHATAEMIA 48 0.0065
146 BEHAVIOUR DISORDER 35 0.0065
147 HYPOKALAEMIA 298 0.0064
148 FOETAL GROWTH RESTRICTION 39 0.0064
149 BLOOD CALCIUM DECREASED 72 0.0064
150 BLOOD CHLORIDE INCREASED 11 0.0064
151 COLITIS 239 0.0063
152 NEUTROPENIC SEPSIS 45 0.0063
153 FREQUENT BOWEL MOVEMENTS 170 0.0063
154 NEUTROPENIC COLITIS 13 0.0063
155 TACHYPNOEA 85 0.0062
156 VENTRICULAR TACHYCARDIA 103 0.0062
157 BACTERAEMIA 74 0.0062
158 INTRA-UTERINE DEATH 10 0.0062
159 FAILURE TO THRIVE 32 0.0062
160 STATUS EPILEPTICUS 69 0.0061
161 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 13 0.0061
162 FEBRILE NEUTROPENIA 399 0.0060
163 PULSELESS ELECTRICAL ACTIVITY 25 0.0060
164 ENCEPHALOPATHY 146 0.0059
165 PROTEIN TOTAL DECREASED 22 0.0058
166 NEPHROGENIC ANAEMIA 27 0.0058
167 ENTEROCOCCAL INFECTION 28 0.0058
168 ACIDOSIS 44 0.0058
169 BLOOD PHOSPHORUS DECREASED 21 0.0057
170 RESPIRATORY RATE DECREASED 18 0.0057
171 FEAR 154 0.0057
172 URINE OUTPUT DECREASED 50 0.0057
173 DEVICE INFUSION ISSUE 14 0.0056
174 INTRAVENTRICULAR HAEMORRHAGE 14 0.0056
175 CYTOMEGALOVIRUS VIRAEMIA 25 0.0056
176 LIVE BIRTH 47 0.0056
177 CYTOMEGALOVIRUS TEST POSITIVE 10 0.0056
178 ADRENAL INSUFFICIENCY 68 0.0056
179 BILIRUBIN CONJUGATED INCREASED 13 0.0056
180 ELECTROCARDIOGRAM QT PROLONGED 199 0.0055
181 STAPHYLOCOCCAL SEPSIS 27 0.0055
182 HYPOPROTEINAEMIA 10 0.0053
183 DERMATITIS ACNEIFORM 32 0.0053
184 MATERNAL DRUGS AFFECTING FOETUS 40 0.0052
185 SINUS TACHYCARDIA 74 0.0052
186 VENTRICULAR EXTRASYSTOLES 54 0.0052
187 BLOOD CREATININE DECREASED 16 0.0051
188 RENAL TUBULAR NECROSIS 50 0.0051
189 PNEUMONIA FUNGAL 20 0.0051
190 SUPRAVENTRICULAR EXTRASYSTOLES 17 0.0050
191 GRAFT VERSUS HOST DISEASE 36 0.0050
192 ENDOTRACHEAL INTUBATION 14 0.0050
193 GRAFT VERSUS HOST DISEASE IN SKIN 11 0.0050
194 ELECTROCARDIOGRAM T WAVE INVERSION 11 0.0050
195 NORMAL NEWBORN 27 0.0050
196 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 13 0.0050
197 VENTRICULAR FIBRILLATION 55 0.0049
198 VENTRICULAR ARRHYTHMIA 18 0.0049
199 HYPERURICAEMIA 20 0.0049
200 RECTAL HAEMORRHAGE 209 0.0049
201 ENTEROCOLITIS 28 0.0048
202 PULMONARY OEDEMA 217 0.0048
203 TACHYARRHYTHMIA 12 0.0048
204 AUTONOMIC NERVOUS SYSTEM IMBALANCE 14 0.0048
205 ANORGASMIA 13 0.0048
206 DISSEMINATED INTRAVASCULAR COAGULATION 67 0.0048
207 ACUTE RESPIRATORY DISTRESS SYNDROME 84 0.0047
208 INTESTINAL ISCHAEMIA 26 0.0047
209 BLOOD CULTURE POSITIVE 14 0.0047
210 CEREBROVASCULAR DISORDER 14 0.0046
211 STAPHYLOCOCCAL BACTERAEMIA 20 0.0046
212 DRUG EXPOSURE DURING PREGNANCY 156 0.0046
213 ANHEDONIA 120 0.0046
214 HYPERBILIRUBINAEMIA 47 0.0045
215 RESPIRATORY DISTRESS 124 0.0045
216 ESCHERICHIA SEPSIS 13 0.0045
217 RENAL INJURY 133 0.0045
218 ELECTROLYTE IMBALANCE 52 0.0045
219 STEM CELL TRANSPLANT 11 0.0044
220 HYPOXIA 155 0.0044
221 HYPERPARATHYROIDISM SECONDARY 11 0.0044
222 ACUTE GRAFT VERSUS HOST DISEASE 20 0.0044
223 APNOEA 34 0.0044
224 HYPERKALAEMIA 153 0.0044
225 RESPIRATORY FAILURE 318 0.0044
226 ENCEPHALITIS 30 0.0043
227 SEPTIC SHOCK 188 0.0043
228 LUNG INFILTRATION 38 0.0043
229 BUNDLE BRANCH BLOCK LEFT 18 0.0042
230 SINUS BRADYCARDIA 41 0.0042
231 PNEUMATOSIS INTESTINALIS 12 0.0042
232 PULSE ABSENT 20 0.0042
233 PARTIAL SEIZURES 22 0.0042
234 FLUID OVERLOAD 61 0.0042
235 VASCULAR DEVICE INFECTION 19 0.0042
236 OLIGURIA 26 0.0042
237 BLOOD UREA INCREASED 70 0.0042
238 INFUSION RELATED REACTION 276 0.0042
239 CLOSTRIDIAL INFECTION 14 0.0041
240 AREFLEXIA 11 0.0041
241 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 21 0.0041
242 STRIDOR 12 0.0041
243 ILEUS PARALYTIC 18 0.0040
244 AORTIC STENOSIS 14 0.0040
245 VARICES OESOPHAGEAL 12 0.0040
246 CLOSTRIDIUM DIFFICILE COLITIS 42 0.0040
247 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 20 0.0039
248 DIASTOLIC DYSFUNCTION 12 0.0039
249 METABOLIC ACIDOSIS 124 0.0039
250 RIGHT VENTRICULAR FAILURE 27 0.0038
251 OESOPHAGITIS 42 0.0038
252 BLOOD CREATINE INCREASED 17 0.0038
253 RESPIRATORY RATE INCREASED 34 0.0038
254 ATRIAL SEPTAL DEFECT 32 0.0038
255 FLUID INTAKE REDUCED 19 0.0038
256 GESTATIONAL DIABETES 18 0.0038
257 TRICUSPID VALVE INCOMPETENCE 30 0.0038
258 GASTROINTESTINAL NECROSIS 11 0.0038
259 NYSTAGMUS 20 0.0038
260 RENAL FAILURE ACUTE 159 0.0037
261 HYDRONEPHROSIS 28 0.0037
262 SHOCK 86 0.0037
263 SMALL INTESTINAL OBSTRUCTION 46 0.0037
264 COLITIS ULCERATIVE 167 0.0037
265 PROCTALGIA 24 0.0037
266 SEPSIS 416 0.0037
267 LUMBAR VERTEBRAL FRACTURE 17 0.0037
268 THROMBOPHLEBITIS 13 0.0037
269 PULMONARY HAEMORRHAGE 29 0.0037
270 ILEUS 46 0.0037
271 HYPOVENTILATION 12 0.0037
272 HAEMATOCHEZIA 201 0.0036
273 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 259 0.0036
274 TUMOUR LYSIS SYNDROME 32 0.0036
275 CARDIOGENIC SHOCK 52 0.0036
276 BONE LESION 13 0.0036
277 BLOOD ALKALINE PHOSPHATASE INCREASED 89 0.0036
278 BK VIRUS INFECTION 12 0.0036
279 DEVICE RELATED INFECTION 54 0.0035
280 PSEUDOMONAS INFECTION 30 0.0035
281 MALNUTRITION 39 0.0035
282 BONE DENSITY ABNORMAL 13 0.0035
283 GENERALISED OEDEMA 43 0.0035
284 MATERNAL EXPOSURE TIMING UNSPECIFIED 13 0.0035
285 DECUBITUS ULCER 28 0.0034
286 PERIPHERAL ISCHAEMIA 14 0.0034
287 NEUROTOXICITY 60 0.0034
288 STUPOR 11 0.0034
289 TONGUE OEDEMA 13 0.0034
290 BONE EROSION 12 0.0034
291 MENTAL STATUS CHANGES 94 0.0034
292 RESPIRATORY ARREST 93 0.0034
293 RED CELL DISTRIBUTION WIDTH INCREASED 14 0.0034
294 NORMOCHROMIC NORMOCYTIC ANAEMIA 10 0.0033
295 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 11 0.0033
296 WOUND SECRETION 13 0.0033
297 VENTRICULAR SEPTAL DEFECT 19 0.0033
298 RESPIRATORY DISORDER 99 0.0033
299 COAGULOPATHY 55 0.0033
300 UNRESPONSIVE TO STIMULI 85 0.0033
301 MITRAL VALVE INCOMPETENCE 37 0.0033
302 ATRIAL FLUTTER 26 0.0033
303 CARDIAC ARREST 269 0.0033
304 SUPRAVENTRICULAR TACHYCARDIA 31 0.0032
305 HYPERVOLAEMIA 16 0.0032
306 BRONCHOPULMONARY ASPERGILLOSIS 25 0.0032
307 NEUTROPHIL COUNT DECREASED 131 0.0032
308 BRONCHOPNEUMONIA 11 0.0032
309 PULMONARY ALVEOLAR HAEMORRHAGE 18 0.0032
310 HYPERGLYCAEMIA 116 0.0032
311 PLEURAL EFFUSION 193 0.0032
312 BLOOD POTASSIUM DECREASED 95 0.0032
313 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 53 0.0031
314 CUSHINGOID 10 0.0031
315 JAUNDICE CHOLESTATIC 11 0.0031
316 LOOSE TOOTH 10 0.0031
317 RENAL FAILURE 408 0.0031
318 MUCOSAL INFLAMMATION 80 0.0031
319 PNEUMONIA BACTERIAL 28 0.0030
320 COVID-19 PNEUMONIA 36 0.0030
321 PANCYTOPENIA 170 0.0030
322 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 29 0.0030
323 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 10 0.0030
324 HYPERTRANSAMINASAEMIA 21 0.0030
325 RENAL IMPAIRMENT 253 0.0030
326 HAEMORRHAGE INTRACRANIAL 45 0.0030
327 PROTEIN URINE PRESENT 15 0.0030
328 CARDIOMEGALY 37 0.0030
329 OLIGOHYDRAMNIOS 10 0.0030
330 ASCITES 88 0.0030
331 RENAL FAILURE CHRONIC 23 0.0030
332 PULMONARY HYPERTENSION 62 0.0030
333 ANAEMIA 567 0.0030
334 ABDOMINAL ABSCESS 13 0.0029
335 CARBOHYDRATE ANTIGEN 125 INCREASED 10 0.0029
336 CYANOSIS 46 0.0029
337 BLOOD BILIRUBIN INCREASED 79 0.0029
338 INJURY 204 0.0029
339 LARGE INTESTINE PERFORATION 20 0.0029
340 HYPOTENSION 573 0.0029
341 NECROTISING FASCIITIS 10 0.0028
342 VENOOCCLUSIVE LIVER DISEASE 14 0.0028
343 ASPIRATION 31 0.0028
344 THROMBOCYTOPENIA 316 0.0028
345 CHOLECYSTITIS ACUTE 16 0.0028
346 LEUKOCYTOSIS 51 0.0028
347 ASPARTATE AMINOTRANSFERASE INCREASED 149 0.0028
348 LEFT VENTRICULAR HYPERTROPHY 12 0.0028
349 BRONCHOSPASM 40 0.0028
350 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 21 0.0028
351 INTESTINAL PERFORATION 31 0.0028
352 AZOTAEMIA 11 0.0028
353 PERIPHERAL SENSORY NEUROPATHY 16 0.0027
354 HAEMATOCRIT DECREASED 54 0.0027
355 LYMPHOCYTE COUNT DECREASED 48 0.0027
356 KIDNEY TRANSPLANT REJECTION 13 0.0027
357 HYPOTONIA 27 0.0027
358 ACUTE KIDNEY INJURY 413 0.0027
359 HYPERCHOLESTEROLAEMIA 26 0.0027
360 BRAIN OEDEMA 34 0.0027
361 PERICARDIAL EFFUSION 62 0.0027
362 COLITIS ISCHAEMIC 18 0.0027
363 CARDIAC MURMUR 23 0.0027
364 EMBOLISM 22 0.0026
365 HEPATOMEGALY 26 0.0026
366 BLOOD CREATINE PHOSPHOKINASE INCREASED 76 0.0026
367 BREATH SOUNDS ABNORMAL 13 0.0026
368 THERAPEUTIC PRODUCT EFFECT DELAYED 12 0.0026
369 TROPONIN INCREASED 20 0.0026
370 LACTIC ACIDOSIS 85 0.0026
371 GRAND MAL CONVULSION 24 0.0026
372 ESCHERICHIA URINARY TRACT INFECTION 11 0.0026
373 MULTIPLE ORGAN DYSFUNCTION SYNDROME 73 0.0026
374 GASTRITIS EROSIVE 12 0.0026
375 DYSPEPSIA 253 0.0026
376 TACHYCARDIA 228 0.0026
377 BLOOD CREATININE INCREASED 165 0.0025
378 PROTEINURIA 48 0.0025
379 WHITE BLOOD CELL COUNT ABNORMAL 16 0.0025
380 ENTERITIS 16 0.0025
381 ALANINE AMINOTRANSFERASE INCREASED 153 0.0025
382 PNEUMONIA ASPIRATION 62 0.0025
383 WHEELCHAIR USER 11 0.0025
384 SERUM FERRITIN INCREASED 13 0.0025
385 OSTEOPENIA 37 0.0024
386 HYPONATRAEMIA 137 0.0024
387 HYPERCALCAEMIA 30 0.0024
388 PNEUMONITIS 66 0.0024
389 BLOOD PRESSURE SYSTOLIC DECREASED 11 0.0024
390 CYTOMEGALOVIRUS INFECTION 40 0.0024
391 PRODUCT LABEL CONFUSION 14 0.0024
392 HYPOVOLAEMIA 14 0.0024
393 ATRIOVENTRICULAR BLOCK COMPLETE 16 0.0024
394 UROSEPSIS 22 0.0024
395 UNEVALUABLE EVENT 180 0.0024
396 LOCALISED OEDEMA 11 0.0024
397 MULTIPLE MYELOMA 11 0.0024
398 CARDIOTOXICITY 21 0.0024
399 BLOOD LACTATE DEHYDROGENASE INCREASED 37 0.0023
400 SKIN LESION 64 0.0023
401 PYREXIA 807 0.0023
402 HERPES SIMPLEX 15 0.0023
403 DRUG LEVEL INCREASED 38 0.0023
404 BRAIN INJURY 23 0.0023
405 TRANSFUSION 24 0.0023
406 DUODENAL ULCER PERFORATION 17 0.0023
407 WOUND INFECTION 25 0.0023
408 GROIN PAIN 20 0.0023
409 CHOLECYSTITIS 27 0.0023
410 CARDIAC FAILURE ACUTE 15 0.0022
411 NEUTROPHIL COUNT INCREASED 23 0.0022
412 STAPHYLOCOCCAL INFECTION 74 0.0022
413 PLATELET COUNT DECREASED 238 0.0022
414 ATRIAL FIBRILLATION 217 0.0022
415 ABDOMINAL TENDERNESS 11 0.0022
416 SHOCK HAEMORRHAGIC 18 0.0022
417 RESPIRATORY DEPRESSION 27 0.0022
418 OXYGEN SATURATION DECREASED 123 0.0022
419 HYPERLIPIDAEMIA 26 0.0022
420 ENDOCARDITIS 11 0.0021
421 NEPHROPATHY TOXIC 24 0.0021
422 HYPOGAMMAGLOBULINAEMIA 14 0.0021
423 MIOSIS 17 0.0021
424 BRADYCARDIA 112 0.0021
425 MALABSORPTION 11 0.0021
426 STRESS CARDIOMYOPATHY 12 0.0021
427 HEPATIC FAILURE 62 0.0021
428 THROMBOTIC MICROANGIOPATHY 20 0.0021
429 ANAL ABSCESS 11 0.0020
430 ABDOMINAL PAIN 474 0.0020
431 HYPOPHAGIA 52 0.0020
432 END STAGE RENAL DISEASE 37 0.0020
433 FLANK PAIN 19 0.0020
434 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 111 0.0020
435 HYDROCEPHALUS 11 0.0020
436 PROTHROMBIN TIME PROLONGED 12 0.0020
437 EXTRASYSTOLES 14 0.0020
438 DELIRIUM 69 0.0020
439 GASTROENTERITIS 29 0.0020
440 DUODENAL ULCER 14 0.0020
441 BACTERIAL INFECTION 37 0.0020
442 MYASTHENIA GRAVIS 16 0.0020
443 DEHYDRATION 264 0.0020
444 KLEBSIELLA INFECTION 10 0.0020
445 NO THERAPEUTIC RESPONSE 24 0.0020
446 HYPERTHERMIA 15 0.0020
447 APHASIA 59 0.0020
448 PERONEAL NERVE PALSY 11 0.0019
449 SPINAL COMPRESSION FRACTURE 16 0.0019
450 LUNG INFECTION 30 0.0019
451 HIATUS HERNIA 25 0.0019
452 WRONG PRODUCT ADMINISTERED 13 0.0019
453 BODY TEMPERATURE INCREASED 39 0.0019
454 RED BLOOD CELL SEDIMENTATION RATE INCREASED 21 0.0019
455 HYPERTRIGLYCERIDAEMIA 11 0.0019
456 TRANSPLANT REJECTION 15 0.0019
457 BLOOD DISORDER 15 0.0019
458 C-REACTIVE PROTEIN INCREASED 68 0.0019
459 COMPRESSION FRACTURE 10 0.0019
460 EJECTION FRACTION DECREASED 29 0.0019
461 NEUTROPENIA 253 0.0019
462 PYELONEPHRITIS 16 0.0018
463 RASH MACULO-PAPULAR 41 0.0018
464 IRON DEFICIENCY ANAEMIA 17 0.0018
465 WHEEZING 109 0.0018
466 DRUG TOXICITY 25 0.0018
467 STOMATITIS 111 0.0018
468 CONSTIPATION 399 0.0018
469 PNEUMOTHORAX 29 0.0018
470 INTERNATIONAL NORMALISED RATIO INCREASED 52 0.0018
471 ESCHERICHIA INFECTION 15 0.0018
472 POST PROCEDURAL COMPLICATION 35 0.0018
473 PULMONARY CONGESTION 24 0.0018
474 TRANSAMINASES INCREASED 40 0.0018
475 WRONG DRUG ADMINISTERED 16 0.0018
476 ARRHYTHMIA 85 0.0018
477 ANOREXIA 23 0.0018
478 LIP SWELLING 59 0.0018
479 DEPRESSED LEVEL OF CONSCIOUSNESS 70 0.0018
480 ANGIOEDEMA 78 0.0018
481 RENAL CYST 14 0.0018
482 CIRCULATORY COLLAPSE 30 0.0018
483 OEDEMA 95 0.0017
484 BONE MARROW FAILURE 35 0.0017
485 HEPATIC FUNCTION ABNORMAL 64 0.0017
486 HYPERAESTHESIA 14 0.0017
487 LEUKOPENIA 85 0.0017
488 BLOOD TRIGLYCERIDES INCREASED 30 0.0017
489 LIPASE INCREASED 13 0.0017
490 SUBDURAL HAEMATOMA 24 0.0017
491 OEDEMA PERIPHERAL 204 0.0017
492 DYSGRAPHIA 11 0.0017
493 GANGRENE 10 0.0017
494 INGUINAL HERNIA 10 0.0016
495 PERITONITIS 34 0.0016
496 GASTRITIS 43 0.0016
497 POST PROCEDURAL HAEMORRHAGE 19 0.0016
498 GENERALISED TONIC-CLONIC SEIZURE 27 0.0016
499 ANURIA 14 0.0016
500 PSYCHOLOGICAL TRAUMA 14 0.0016
501 RHINITIS 13 0.0016
502 HEPATIC ENCEPHALOPATHY 15 0.0016
503 CLOSTRIDIUM DIFFICILE INFECTION 35 0.0016
504 HYPOTHYROIDISM 51 0.0016
505 BLOOD PRESSURE DECREASED 106 0.0016
506 MEDICATION ERROR 88 0.0016
507 HYPOTHERMIA 16 0.0016
508 GAMMA-GLUTAMYLTRANSFERASE INCREASED 35 0.0016
509 WHITE BLOOD CELL COUNT INCREASED 60 0.0016
510 MYOSITIS 14 0.0016
511 PULMONARY TOXICITY 11 0.0016
512 ATRIOVENTRICULAR BLOCK 12 0.0016
513 CONGENITAL ANOMALY 12 0.0015
514 HAEMOGLOBIN DECREASED 159 0.0015
515 DIVERTICULUM 11 0.0015
516 CELLULITIS 78 0.0015
517 UPPER GASTROINTESTINAL HAEMORRHAGE 26 0.0015
518 MELAENA 34 0.0015
519 PNEUMONIA 499 0.0015
520 PATHOGEN RESISTANCE 14 0.0015
521 RESPIRATORY TRACT INFECTION 40 0.0015
522 ASPERGILLUS INFECTION 10 0.0015
523 DEEP VEIN THROMBOSIS 99 0.0015
524 DRUG INTERACTION 240 0.0015
525 HAEMOPTYSIS 42 0.0015
526 MOUTH HAEMORRHAGE 11 0.0015
527 EMOTIONAL DISTRESS 181 0.0015
528 ERYTHEMA 307 0.0015
529 RESPIRATORY SYNCYTIAL VIRUS INFECTION 13 0.0015
530 EMPHYSEMA 15 0.0015
531 BLOOD SODIUM DECREASED 28 0.0015
532 STEVENS-JOHNSON SYNDROME 33 0.0015
533 LIVER FUNCTION TEST ABNORMAL 43 0.0015
534 ACUTE MYELOID LEUKAEMIA 23 0.0015
535 GLOMERULAR FILTRATION RATE DECREASED 18 0.0015
536 ANAPHYLACTIC REACTION 80 0.0014
537 TUBULOINTERSTITIAL NEPHRITIS 27 0.0014
538 OBSTRUCTIVE AIRWAYS DISORDER 16 0.0014
539 PETECHIAE 15 0.0014
540 CARDIO-RESPIRATORY ARREST 60 0.0014
541 DYSPNOEA EXERTIONAL 54 0.0014
542 CHILLS 168 0.0014
543 HAEMATOMA 37 0.0014
544 INTERSTITIAL LUNG DISEASE 69 0.0014
545 JOINT DISLOCATION 15 0.0014
546 BLOOD POTASSIUM INCREASED 23 0.0014
547 DISABILITY 28 0.0014
548 WEIGHT DECREASED 391 0.0014
549 CEREBRAL HAEMORRHAGE 50 0.0014
550 ERYTHEMA MULTIFORME 13 0.0014
551 LETHARGY 80 0.0014
552 DISEASE RECURRENCE 66 0.0014
553 ALTERED STATE OF CONSCIOUSNESS 30 0.0014
554 HEPATIC CIRRHOSIS 26 0.0014
555 CARDIAC FAILURE 111 0.0014
556 SPINAL OSTEOARTHRITIS 12 0.0014
557 CARDIAC FAILURE CONGESTIVE 109 0.0014
558 WHITE BLOOD CELL COUNT DECREASED 147 0.0014
559 CHOLESTASIS 26 0.0014
560 CARDIOMYOPATHY 20 0.0014
561 LOWER GASTROINTESTINAL HAEMORRHAGE 10 0.0014
562 CEREBRAL INFARCTION 33 0.0013
563 POLYURIA 11 0.0013
564 HAEMATURIA 46 0.0013
565 DYSURIA 49 0.0013
566 NEURALGIA 32 0.0013
567 ANXIETY 374 0.0013
568 HAEMODIALYSIS 11 0.0013
569 PANCREATITIS 69 0.0013
570 FACIAL PARALYSIS 11 0.0013
571 ACUTE MYOCARDIAL INFARCTION 38 0.0013
572 THIRST 23 0.0013
573 PALLOR 35 0.0013
574 BLOOD GLUCOSE FLUCTUATION 14 0.0013
575 ELECTROCARDIOGRAM ABNORMAL 10 0.0013
576 MYOPATHY 11 0.0013
577 LYMPHOPENIA 18 0.0013
578 DIALYSIS 18 0.0013
579 DYSPHAGIA 120 0.0013
580 ORTHOSTATIC HYPOTENSION 22 0.0013
581 FURUNCLE 10 0.0013
582 HYPOGLYCAEMIA 61 0.0013
583 ECONOMIC PROBLEM 19 0.0013
584 NEUROPATHY PERIPHERAL 119 0.0012
585 PRODUCT USE IN UNAPPROVED INDICATION 310 0.0012
586 CHOLELITHIASIS 41 0.0012
587 MUSCULAR WEAKNESS 142 0.0012
588 SKIN ULCER 32 0.0012
589 GENERAL PHYSICAL HEALTH DETERIORATION 143 0.0012
590 MUSCULOSKELETAL CHEST PAIN 19 0.0012
591 PULMONARY EMBOLISM 116 0.0012
592 DEVELOPMENTAL DELAY 11 0.0012
593 HICCUPS 10 0.0012
594 MUSCLE INJURY 10 0.0012
595 SLEEP APNOEA SYNDROME 23 0.0012
596 SKIN LACERATION 13 0.0012
597 SPLENOMEGALY 14 0.0012
598 HYPERTENSION 253 0.0012
599 INTESTINAL OBSTRUCTION 45 0.0012
600 CONFUSIONAL STATE 192 0.0012
601 DRUG ERUPTION 21 0.0012
602 THERAPY NON-RESPONDER 53 0.0012
603 SUBARACHNOID HAEMORRHAGE 12 0.0012
604 PULMONARY ARTERIAL HYPERTENSION 17 0.0012
605 GASTROINTESTINAL HAEMORRHAGE 98 0.0012
606 PAIN 719 0.0012
607 ARTERIOSCLEROSIS 11 0.0012
608 ECZEMA 61 0.0012
609 POISONING DELIBERATE 11 0.0012
610 VOMITING 544 0.0012
611 URINARY TRACT INFECTION 197 0.0012
612 ASTHMA 130 0.0011
613 WEIGHT FLUCTUATION 12 0.0011
614 PULMONARY FIBROSIS 22 0.0011
615 FOLLICULITIS 12 0.0011
616 URINARY RETENTION 38 0.0011
617 GRIP STRENGTH DECREASED 10 0.0011
618 CHEST PAIN 208 0.0011
619 RESTLESSNESS 41 0.0011
620 CHRONIC KIDNEY DISEASE 85 0.0011
621 BODY TEMPERATURE DECREASED 11 0.0011
622 DYSARTHRIA 42 0.0011
623 FEELING COLD 31 0.0011
624 DRUG DISPENSING ERROR 17 0.0011
625 ABDOMINAL DISTENSION 116 0.0011
626 DISEASE PROGRESSION 130 0.0011
627 BONE DISORDER 20 0.0011
628 METASTASES TO BONE 18 0.0011
629 DYSPNOEA 620 0.0011
630 EXOSTOSIS 10 0.0011
631 LOSS OF CONSCIOUSNESS 140 0.0011
632 NAUSEA 863 0.0011
633 CORONARY ARTERY DISEASE 33 0.0011
634 EOSINOPHILIA 19 0.0011
635 DIVERTICULITIS 30 0.0011
636 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 52 0.0011
637 DIABETIC KETOACIDOSIS 26 0.0011
638 TOOTH ABSCESS 11 0.0011
639 SYNCOPE 108 0.0011
640 MALAISE 471 0.0011
641 HEPATIC STEATOSIS 20 0.0011
642 IMMUNODEFICIENCY 16 0.0011
643 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 11 0.0011
644 APPENDICITIS 10 0.0011
645 SKIN IRRITATION 49 0.0011
646 CYSTITIS 34 0.0011
647 TRANSIENT ISCHAEMIC ATTACK 36 0.0011
648 CONVULSION 61 0.0011
649 CANDIDA INFECTION 18 0.0011
650 FEELING HOT 65 0.0011
651 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 55 0.0011
652 OSTEOMYELITIS 19 0.0010
653 EPISTAXIS 78 0.0010
654 BACK PAIN 242 0.0010
655 SEIZURE 120 0.0010
656 COMPLICATION ASSOCIATED WITH DEVICE 15 0.0010
657 DIARRHOEA 665 0.0010
658 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 24 0.0010
659 AUTOIMMUNE DISORDER 10 0.0010
660 HAEMORRHOIDS 20 0.0010
661 ACUTE HEPATIC FAILURE 14 0.0010
662 CONTRAINDICATED PRODUCT ADMINISTERED 31 0.0010
663 SKIN DISCOLOURATION 47 0.0010
664 UPPER RESPIRATORY TRACT INFECTION 47 0.0010
665 RED BLOOD CELL COUNT DECREASED 29 0.0010
666 INFUSION SITE PAIN 13 0.0010
667 RHABDOMYOLYSIS 42 0.0010
668 MYOCLONUS 12 0.0010
669 CHEST DISCOMFORT 103 0.0010
670 ABSCESS 16 0.0010
671 GASTRIC ULCER 19 0.0010
672 PLATELET COUNT INCREASED 13 0.0010
673 MOUTH ULCERATION 21 0.0010
674 DECREASED APPETITE 231 0.0010
675 FOOT DEFORMITY 11 0.0010
676 ORAL PAIN 22 0.0010
677 OFF LABEL USE 859 0.0010
678 FISTULA 11 0.0010
679 MALIGNANT NEOPLASM PROGRESSION 100 0.0010
680 ASTHENIA 365 0.0010
681 LIVER DISORDER 43 0.0010
682 VAGINAL HAEMORRHAGE 42 0.0010
683 MYOCARDIAL ISCHAEMIA 11 0.0010
684 JAUNDICE 26 0.0010
685 COLD SWEAT 17 0.0010
686 HYPOKINESIA 14 0.0010
687 GASTROOESOPHAGEAL REFLUX DISEASE 77 0.0010
688 BLOOD PRESSURE ABNORMAL 19 0.0010
689 FLUSHING 97 0.0010
690 DERMATITIS ALLERGIC 12 0.0010
691 MUSCLE ATROPHY 12 0.0009
692 INCONTINENCE 10 0.0009
693 ULCER 15 0.0009
694 OBESITY 15 0.0009
695 DRUG INEFFECTIVE 1236 0.0009
696 MYDRIASIS 12 0.0009
697 LIVER FUNCTION TEST INCREASED 20 0.0009
698 NECK PAIN 52 0.0009
699 NEUROLEPTIC MALIGNANT SYNDROME 11 0.0009
700 BLOOD IRON DECREASED 11 0.0009
701 RIB FRACTURE 19 0.0009
702 BLOOD PRESSURE SYSTOLIC INCREASED 18 0.0009
703 RASH ERYTHEMATOUS 44 0.0009
704 OSTEOARTHRITIS 39 0.0009
705 BLOOD PRESSURE FLUCTUATION 22 0.0009
706 AGRANULOCYTOSIS 17 0.0009
707 DENTAL CARIES 10 0.0009
708 CONDITION AGGRAVATED 274 0.0009
709 OSTEOPOROSIS 37 0.0009
710 HYPERTENSIVE CRISIS 10 0.0009
711 MUSCULOSKELETAL PAIN 47 0.0009
712 DRUG RESISTANCE 23 0.0009
713 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 23 0.0009
714 PERICARDITIS 15 0.0009
715 ANAPHYLACTIC SHOCK 23 0.0009
716 TOXICITY TO VARIOUS AGENTS 150 0.0009
717 PALPITATIONS 104 0.0009
718 CHROMATURIA 20 0.0009
719 HEART RATE DECREASED 31 0.0009
720 POOR QUALITY SLEEP 19 0.0009
721 GINGIVAL BLEEDING 12 0.0009
722 SEDATION 23 0.0009
723 PULMONARY MASS 13 0.0009
724 BLISTER 49 0.0009
725 SKIN DISORDER 29 0.0009
726 MUSCLE TWITCHING 20 0.0009
727 TREMOR 144 0.0009
728 METASTASES TO LUNG 10 0.0009
729 PRESYNCOPE 21 0.0009
730 COORDINATION ABNORMAL 12 0.0009
731 DISORIENTATION 34 0.0009
732 AGITATION 63 0.0009
733 INFECTION 124 0.0009
734 METASTASES TO LIVER 15 0.0009
735 PAIN IN JAW 24 0.0008
736 DEPRESSION 192 0.0008
737 ISCHAEMIC STROKE 15 0.0008
738 COMA 40 0.0008
739 SOMNOLENCE 169 0.0008
740 DYSPHONIA 49 0.0008
741 HEART RATE INCREASED 83 0.0008
742 RENAL DISORDER 39 0.0008
743 SEROTONIN SYNDROME 16 0.0008
744 TYPE 2 DIABETES MELLITUS 28 0.0008
745 MYELODYSPLASTIC SYNDROME 12 0.0008
746 HAEMATEMESIS 21 0.0008
747 PRODUCT PREPARATION ERROR 17 0.0008
748 HEMIPARESIS 14 0.0008
749 SCIATICA 13 0.0008
750 LIVER INJURY 20 0.0008
751 CEREBROVASCULAR ACCIDENT 138 0.0008
752 BURNING SENSATION 57 0.0008
753 RASH GENERALISED 21 0.0008
754 PANCREATITIS ACUTE 18 0.0008
755 AMNESIA 52 0.0008
756 IMPAIRED HEALING 26 0.0008
757 ABDOMINAL PAIN LOWER 20 0.0008
758 DYSSTASIA 23 0.0008
759 BLOOD PRESSURE INCREASED 120 0.0008
760 LOWER LIMB FRACTURE 15 0.0008
761 METASTASES TO CENTRAL NERVOUS SYSTEM 10 0.0008
762 TENDONITIS 12 0.0008
763 EAR PAIN 15 0.0008
764 PARALYSIS 11 0.0008
765 DRUG-INDUCED LIVER INJURY 24 0.0008
766 PARAESTHESIA 119 0.0008
767 EAR INFECTION 20 0.0008
768 WOUND 21 0.0008
769 PREGNANCY 15 0.0007
770 CARDIOVASCULAR DISORDER 19 0.0007
771 CONTUSION 72 0.0007
772 EMOTIONAL DISORDER 23 0.0007
773 FOOT FRACTURE 14 0.0007
774 COLON CANCER 11 0.0007
775 FAECES DISCOLOURED 16 0.0007
776 SLEEP DISORDER 52 0.0007
777 TREATMENT NONCOMPLIANCE 40 0.0007
778 MULTIPLE FRACTURES 12 0.0007
779 HYPERHIDROSIS 94 0.0007
780 HYPOAESTHESIA 109 0.0007
781 HEADACHE 456 0.0007
782 HAEMORRHAGE 76 0.0007
783 GASTROENTERITIS VIRAL 13 0.0007
784 HEPATOTOXICITY 16 0.0007
785 TOOTHACHE 13 0.0007
786 ORAL HERPES 14 0.0007
787 GLOSSODYNIA 16 0.0007
788 ACCIDENTAL OVERDOSE 26 0.0007
789 ANKLE FRACTURE 11 0.0007
790 MOBILITY DECREASED 51 0.0007
791 COUGH 199 0.0007
792 LYMPHADENOPATHY 25 0.0007
793 FALL 235 0.0007
794 NERVOUS SYSTEM DISORDER 22 0.0007
795 CONJUNCTIVITIS 13 0.0007
796 URTICARIA 117 0.0007
797 RASH 304 0.0007
798 DRUG INTOLERANCE 67 0.0007
799 GAIT INABILITY 23 0.0007
800 ABASIA 17 0.0007
801 BLOOD CHOLESTEROL INCREASED 32 0.0007
802 INTERVERTEBRAL DISC PROTRUSION 15 0.0007
803 LOWER RESPIRATORY TRACT INFECTION 31 0.0007
804 INCREASED APPETITE 13 0.0007
805 URINARY INCONTINENCE 20 0.0007
806 LUNG DISORDER 33 0.0007
807 PRODUCT PRESCRIBING ERROR 16 0.0007
808 PRODUCTIVE COUGH 32 0.0007
809 NERVOUSNESS 35 0.0007
810 GOUT 12 0.0007
811 THROAT IRRITATION 30 0.0007
812 HEPATITIS 17 0.0007
813 HEART RATE IRREGULAR 15 0.0007
814 ERECTILE DYSFUNCTION 17 0.0007
815 LOCALISED INFECTION 16 0.0007
816 HEPATIC ENZYME INCREASED 45 0.0007
817 RESTLESS LEGS SYNDROME 12 0.0007
818 PANIC ATTACK 24 0.0007
819 ACTIVITIES OF DAILY LIVING IMPAIRED 13 0.0007
820 INTENTIONAL OVERDOSE 42 0.0007
821 MUSCLE SPASMS 120 0.0007
822 TINNITUS 30 0.0007
823 FACE OEDEMA 11 0.0007
824 RHINORRHOEA 42 0.0006
825 OROPHARYNGEAL PAIN 60 0.0006
826 JOINT STIFFNESS 17 0.0006
827 LABORATORY TEST ABNORMAL 19 0.0006
828 PSYCHOTIC DISORDER 19 0.0006
829 SCAR 11 0.0006
830 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 11 0.0006
831 MUSCULOSKELETAL DISCOMFORT 11 0.0006
832 PHOTOPHOBIA 12 0.0006
833 DYSGEUSIA 47 0.0006
834 NEOPLASM PROGRESSION 22 0.0006
835 FATIGUE 491 0.0006
836 FLUID RETENTION 32 0.0006
837 RASH PRURITIC 34 0.0006
838 POLLAKIURIA 26 0.0006
839 ABDOMINAL PAIN UPPER 128 0.0006
840 MENTAL DISORDER 27 0.0006
841 DERMATITIS 13 0.0006
842 DIZZINESS 306 0.0006
843 RETCHING 13 0.0006
844 OSTEONECROSIS OF JAW 15 0.0006
845 SINUS DISORDER 12 0.0006
846 COVID-19 106 0.0006
847 PRESCRIBED UNDERDOSE 12 0.0006
848 VIRAL INFECTION 20 0.0006
849 FLATULENCE 34 0.0006
850 BLOOD GLUCOSE ABNORMAL 11 0.0006
851 ILL-DEFINED DISORDER 36 0.0006
852 THROAT TIGHTNESS 16 0.0006
853 DYSKINESIA 24 0.0006
854 THROMBOSIS 47 0.0006
855 BLOOD URINE PRESENT 11 0.0006
856 MUSCULOSKELETAL DISORDER 11 0.0006
857 CRYING 21 0.0006
858 FUNGAL INFECTION 19 0.0006
859 SWELLING FACE 37 0.0006
860 PLASMA CELL MYELOMA 22 0.0006
861 BLOOD GLUCOSE DECREASED 27 0.0006
862 NIGHT SWEATS 18 0.0006
863 COGNITIVE DISORDER 26 0.0006
864 INSOMNIA 148 0.0006
865 PRURITUS GENERALISED 12 0.0006
866 WEIGHT INCREASED 124 0.0006
867 PAIN IN EXTREMITY 162 0.0005
868 EYE DISORDER 18 0.0005
869 MIGRAINE 52 0.0005
870 FEEDING DISORDER 11 0.0005
871 BRONCHITIS 40 0.0005
872 FIBROMYALGIA 13 0.0005
873 MYALGIA 90 0.0005
874 INTENTIONAL PRODUCT USE ISSUE 46 0.0005
875 NEPHROLITHIASIS 24 0.0005
876 DRY EYE 26 0.0005
877 ABDOMINAL DISCOMFORT 87 0.0005
878 HALLUCINATION 39 0.0005
879 GAIT DISTURBANCE 99 0.0005
880 SPEECH DISORDER 27 0.0005
881 JOINT INJURY 11 0.0005
882 CARDIAC DISORDER 48 0.0005
883 SWELLING 48 0.0005
884 VERTIGO 31 0.0005
885 ABNORMAL BEHAVIOUR 20 0.0005
886 MEMORY IMPAIRMENT 69 0.0005
887 DIPLOPIA 13 0.0005
888 INFLUENZA LIKE ILLNESS 41 0.0005
889 MENTAL IMPAIRMENT 12 0.0005
890 DISCOMFORT 30 0.0005
891 HOT FLUSH 37 0.0005
892 HYPOACUSIS 21 0.0005
893 HERPES ZOSTER 28 0.0005
894 LIMB DISCOMFORT 15 0.0005
895 EYE SWELLING 18 0.0005
896 BONE PAIN 28 0.0005
897 VISION BLURRED 65 0.0005
898 DIABETES MELLITUS 36 0.0005
899 TREATMENT FAILURE 39 0.0005
900 PRODUCT SUBSTITUTION ISSUE 27 0.0005
901 BLOOD GLUCOSE INCREASED 88 0.0005
902 IRRITABLE BOWEL SYNDROME 10 0.0005
903 MYOCARDIAL INFARCTION 81 0.0005
904 DISTURBANCE IN ATTENTION 25 0.0005
905 LACRIMATION INCREASED 14 0.0005
906 DEATH 396 0.0005
907 PRURITUS 176 0.0005
908 RASH MACULAR 16 0.0005
909 OSTEONECROSIS 15 0.0005
910 ANGINA PECTORIS 13 0.0005
911 HYPERSOMNIA 13 0.0005
912 SYSTEMIC LUPUS ERYTHEMATOSUS 16 0.0005
913 INFLUENZA 50 0.0004
914 VISUAL IMPAIRMENT 55 0.0004
915 HEAD INJURY 14 0.0004
916 PERIPHERAL SWELLING 68 0.0004
917 AGGRESSION 22 0.0004
918 SKIN EXFOLIATION 37 0.0004
919 ALOPECIA 86 0.0004
920 ARTHRITIS 34 0.0004
921 DEMENTIA 12 0.0004
922 OVERDOSE 92 0.0004
923 EPILEPSY 13 0.0004
924 PHARMACEUTICAL PRODUCT COMPLAINT 11 0.0004
925 MUSCULOSKELETAL STIFFNESS 37 0.0004
926 SINUSITIS 43 0.0004
927 ARTHRALGIA 174 0.0004
928 PAIN OF SKIN 11 0.0004
929 HIP FRACTURE 13 0.0004
930 DRUG ADMINISTRATION ERROR 12 0.0004
931 JOINT SWELLING 47 0.0004
932 MYELOSUPPRESSION 14 0.0004
933 INFLAMMATION 20 0.0004
934 FEMUR FRACTURE 12 0.0004
935 SWOLLEN TONGUE 12 0.0004
936 ROAD TRAFFIC ACCIDENT 16 0.0004
937 DEAFNESS 10 0.0004
938 ILLNESS 39 0.0004
939 NASAL CONGESTION 22 0.0004
940 FEELING ABNORMAL 89 0.0004
941 BALANCE DISORDER 32 0.0004
942 DRY MOUTH 30 0.0004
943 PSORIATIC ARTHROPATHY 15 0.0004
944 LIMB INJURY 10 0.0004
945 IRRITABILITY 22 0.0004
946 NASOPHARYNGITIS 67 0.0004
947 ARTHROPATHY 20 0.0004
948 GASTROINTESTINAL DISORDER 32 0.0004
949 CATARACT 21 0.0004
950 HYPERSENSITIVITY 65 0.0003
951 THERAPEUTIC RESPONSE DECREASED 21 0.0003
952 MOVEMENT DISORDER 11 0.0003
953 SURGERY 20 0.0003
954 HOSPITALISATION 52 0.0003
955 INCORRECT DOSE ADMINISTERED 76 0.0003
956 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 11 0.0003
957 PRODUCT USE ISSUE 61 0.0003
958 BONE DENSITY DECREASED 10 0.0003
959 EYE PAIN 18 0.0003
960 OCULAR HYPERAEMIA 15 0.0003
961 NEOPLASM MALIGNANT 21 0.0003
962 DEPRESSED MOOD 16 0.0003
963 SUICIDE ATTEMPT 18 0.0003
964 MULTIPLE SCLEROSIS 14 0.0003
965 GASTRIC DISORDER 10 0.0003
966 THERAPEUTIC PRODUCT EFFECT DECREASED 13 0.0003
967 RHEUMATOID ARTHRITIS 32 0.0003
968 BLINDNESS 11 0.0003
969 ADVERSE EVENT 24 0.0003
970 DRY SKIN 33 0.0002
971 LUNG NEOPLASM MALIGNANT 10 0.0002
972 INTENTIONAL PRODUCT MISUSE 20 0.0002
973 DRUG WITHDRAWAL SYNDROME 20 0.0002
974 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 16 0.0002
975 MULTIPLE SCLEROSIS RELAPSE 15 0.0002
976 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 39 0.0002
977 PSORIASIS 28 0.0002
978 ADVERSE DRUG REACTION 19 0.0002
979 DRUG ABUSE 17 0.0002
980 DEVICE MALFUNCTION 14 0.0002
981 PRODUCT DOSE OMISSION ISSUE 56 0.0002
982 INJECTION SITE ERYTHEMA 22 0.0002
983 NO ADVERSE EVENT 32 0.0002
984 EYE IRRITATION 10 0.0002
985 SUICIDAL IDEATION 14 0.0002
986 DRUG DOSE OMISSION 24 0.0001
987 INJECTION SITE HAEMORRHAGE 11 0.0001
988 ACCIDENTAL EXPOSURE TO PRODUCT 14 0.0001
989 COMPLETED SUICIDE 11 0.0001
990 ACNE 10 0.0001
991 INJECTION SITE SWELLING 10 0.0001
992 INJECTION SITE PAIN 33 0.0001
993 PRODUCT QUALITY ISSUE 14 0.0001
994 DRUG DEPENDENCE 13 0.0001